Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA: 600566)

Hubei Jumpcan Pharmaceutical Revenue

Hubei Jumpcan Pharmaceutical had revenue of 1.77B CNY in the quarter ending September 30, 2024, a decrease of -7.18%. This brings the company's revenue in the last twelve months to 8.92B, down -7.43% year-over-year. In the year 2023, Hubei Jumpcan Pharmaceutical had annual revenue of 9.65B with 7.32% growth.

• Revenue (ttm): 8.92B
• Revenue Growth: -7.43%
• P/S Ratio: 3.26
• Revenue / Employee: 1.71M
• Employees: 5,230
• Market Cap: 29.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.65B	658.17M	7.32%
Dec 31, 2022	9.00B	1.37B	17.90%
Dec 31, 2021	7.63B	1.47B	23.77%
Dec 31, 2020	6.16B	-775.02M	-11.17%
Dec 31, 2019	6.94B	-268.21M	-3.72%